Skip to main content

Avalyn Pharma Inc.

corporate_fare Company Profile

Avalyn Pharma Inc.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed AVLN - Latest Insights

AVLN
May 08, 2026, 6:52 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Suvretta Capital Management and Affiliates Disclose 5.6% Stake in Avalyn Pharma Post-IPO, Signaling Strong Conviction
Sentiment: Positive
View Wiseek Article
AVLN
May 08, 2026, 4:41 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
SR One Capital Management Discloses 7.5% Stake in Avalyn Pharma Post-IPO
Sentiment: Neutral
View Wiseek Article
AVLN
May 01, 2026, 6:50 PM EDT
Filing Type: 4
Importance Score:
7
Director Acquires $5 Million in Common Stock at IPO Price Following Company's Public Offering
Sentiment: Positive
View Wiseek Article
AVLN
May 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Avalyn Pharma Finalizes Post-IPO Corporate Charter and Bylaws
Sentiment: Neutral
View Wiseek Article
AVLN
May 01, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Avalyn IPO Closes, Underwriters Fully Exercise Overallotment for $345M Gross Proceeds
Sentiment: Positive
View Wiseek Article
AVLN
Apr 30, 2026, 4:52 PM EDT
Filing Type: 424B4
Importance Score:
9
Avalyn Pharma Finalizes $300 Million Upsized IPO to Fund Clinical Pipeline
Sentiment: Positive
View Wiseek Article
AVLN
Apr 29, 2026, 9:00 PM EDT
Source: GlobeNewswire
Importance Score:
9
Avalyn Pharma Prices Upsized $300M IPO at $18 Per Share
Sentiment: Positive
View Wiseek Article